Question

A 67-year-old woman with type 2 diabetes and prior stroke asks about antiplatelet therapy. According to Canadian stroke secondary prevention recommendations, which strategy is preferred for long-term secondary prevention?

Accepted Answer

Low-dose aspirin monotherapy

Answer

No antiplatelet therapy is required

Answer

Long-term dual antiplatelet therapy with aspirin and clopidogrel

Answer

Warfarin in the absence of atrial fibrillation

Answer

High-dose aspirin 325 mg daily

Practice question

A 67-year-old woman with type 2 diabetes and prior stroke asks about antiplatelet therapy. According to Canadian stroke secondary prevention recommendations, which strategy is preferred for long-term secondary prevention?